VenoStent Inc is a medical device and biomaterial platform company currently resident in JLab Houston. The firm is organized around development of a shape memory polymer wrap designed to enable hemodialysis patients live longer, less painful, and more prosperous lives. Some 430,000 end-stage renal disease (ESRD) patients in the US rely on a procedure - Themodialysis - as theirlieline. Within one year of onset of this treatment, a high percentage of the created access sites (artery-vein connections) in the arm to remove toxins from the blood, collapse and fail. In addition to being expensive, this condition can cause significant morbidity and mortality for patient. VenoStatent has developed SelfWrap - an external stent designed to reduce failures at the vein-graft or vein-artery junction of dialysis patients. The effort is - through use of SelfWrap - to reduce collapse of the vein at this critical interface by promoting outward vein growth and providing durable, flexible, custom-fit mechanical support.
